Cargando…

Inhibition of Cyclin‐Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy

Therapeutic options for patients with advanced‐stage hepatocellular carcinoma (HCC) are very limited. The only approved first‐line treatment is the multi‐tyrosine kinase inhibitor sorafenib, which shows low response rates and severe side effects. In particular, the compensatory activation of growth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ardelt, Maximilian A., Fröhlich, Thomas, Martini, Emanuele, Müller, Martin, Kanitz, Veronika, Atzberger, Carina, Cantonati, Petra, Meßner, Martina, Posselt, Laura, Lehr, Thorsten, Wojtyniak, Jan‐Georg, Ulrich, Melanie, Arnold, Georg J., König, Lars, Parazzoli, Dario, Zahler, Stefan, Rothenfußer, Simon, Mayr, Doris, Gerbes, Alexander, Scita, Giorgio, Vollmar, Angelika M., Pachmayr, Johanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590289/ https://www.ncbi.nlm.nih.gov/pubmed/30033593 http://dx.doi.org/10.1002/hep.30190

Ejemplares similares

Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma
por: Herzog, Julia, et al.
Publicado: (2016)

The long non-coding RNA H19 - a new player in hepatocellular carcinoma
por: Ardelt, Maximilian A., et al.
Publicado: (2017)

Small molecule inhibitors of the mitochondrial ClpXP protease possess cytostatic potential and re-sensitize chemo-resistant cancers
por: Meßner, Martina, et al.
Publicado: (2021)

Data Digitizing: Accurate and Precise Data Extraction for Quantitative Systems Pharmacology and Physiologically‐Based Pharmacokinetic Modeling
por: Wojtyniak, Jan‐Georg, et al.
Publicado: (2020)

Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy
por: Pfitzer, Lisa, et al.
Publicado: (2019)

Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene Interactions
por: Rüdesheim, Simeon, et al.
Publicado: (2020)

To Protect Fatty Livers from Ischemia Reperfusion Injury: Role of Ischemic Postconditioning
por: Schewe, Julia, et al.
Publicado: (2020)

Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis
por: Merk, Henriette, et al.
Publicado: (2016)

Ischemic Postconditioning (IPostC) Protects Fibrotic and Cirrhotic Rat Livers after Warm Ischemia
por: Schewe, Julia, et al.
Publicado: (2019)

The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma
por: Ye, Liangtao, et al.
Publicado: (2019)

Cyclin-dependent kinase inhibitor 2B gene is associated with the sensitivity of hepatoma cells to Sorafenib
por: Weng, Xie, et al.
Publicado: (2019)

A Physiologically Based Pharmacokinetic Model of Ketoconazole and Its Metabolites as Drug–Drug Interaction Perpetrators
por: Marok, Fatima Zahra, et al.
Publicado: (2023)

Spatio-selective activation of nuclear translocation of YAP with light directs invasion of cancer cell spheroids
por: Illes, Bernhard, et al.
Publicado: (2021)

Combined antitumoral effects of pretubulysin and methotrexate
por: Kern, Sarah, et al.
Publicado: (2019)

Spatio‐temporal precipitation climatology over complex terrain using a censored additive regression model
por: Stauffer, Reto, et al.
Publicado: (2016)

Neocarzilin A Is a Potent Inhibitor of Cancer Cell Motility Targeting VAT-1 Controlled Pathways
por: Gleissner, Carolin M.-L., et al.
Publicado: (2019)

Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells
por: Pehserl, Anna-Maria, et al.
Publicado: (2016)

Turning the Actin Nucleating Compound Miuraenamide into Nucleation Inhibitors
por: Wang, Shuaijun, et al.
Publicado: (2021)

Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors
por: Weitensteiner, Sabine B., et al.
Publicado: (2013)

Persistent inhibition of pore-based cell migration by sub-toxic doses of miuraenamide, an actin filament stabilizer
por: Moser, Christina, et al.
Publicado: (2017)

Analogues of Natural Chalcones as Efficient Inhibitors of AKR1C3
por: Möller, Gabriele, et al.
Publicado: (2022)

Disentangling cadherin-mediated cell-cell interactions in collective cancer cell migration
por: Zisis, Themistoklis, et al.
Publicado: (2022)

LC-MS/MS-based proteome profiling in Daphnia pulex and Daphnia longicephala: the Daphnia pulex genome database as a key for high throughput proteomics in Daphnia
por: Fröhlich, Thomas, et al.
Publicado: (2009)

The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells
por: Wang, Jialiang, et al.
Publicado: (2019)

The effect of nanomicelle curcumin, sorafenib, and combination of the two on the cyclin D1 gene expression of the hepatocellular carcinoma cell line (HUH7)
por: Hosseini, Sare, et al.
Publicado: (2019)

The Actin Targeting Compound Chondramide Inhibits Breast Cancer Metastasis via Reduction of Cellular Contractility
por: Menhofer, Magdalena H., et al.
Publicado: (2014)

Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1
por: Lu, Shuai, et al.
Publicado: (2015)

Correction for: The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells
por: Wang, Jialiang, et al.
Publicado: (2019)

Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib
por: Pomej, Katharina, et al.
Publicado: (2021)

Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts
por: Reisinger, Ute, et al.
Publicado: (2009)

Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats
por: Karbownik, Agnieszka, et al.
Publicado: (2020)

Review of rationale and progress toward targeting cyclin-dependent kinase 2 (CDK2) for male contraception(†)
por: Faber, Erik B, et al.
Publicado: (2020)

Inhibition of Cdk5 induces cell death of tumor-initiating cells
por: Mandl, Melanie M, et al.
Publicado: (2017)

ATR Mediates a Checkpoint at the Nuclear Envelope in Response to Mechanical Stress
por: Kumar, Amit, et al.
Publicado: (2014)

El príncipe Siddharta
por: Parazzoli, Ferruccio, 1935-
Publicado: (2000)

IL-18 But Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease
por: Hohenester, Simon, et al.
Publicado: (2020)

Cyclin C: The Story of a Non-Cycling Cyclin
por: Ježek, Jan, et al.
Publicado: (2019)

Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma
por: Ikeda, Atsuyuki, et al.
Publicado: (2021)

Phosphorylation of cyclin O, a novel cyclin family protein containing a cyclin-like domain, is involved in the activation of cyclin-dependent kinase 2
por: KIM, DO HYUNG, et al.
Publicado: (2014)

Tetrapyrrolic Pigments from Heme‐ and Chlorophyll Breakdown are Actin‐Targeting Compounds
por: Karg, Cornelia A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m9uqg5o5ontrd0ugrthhije287